초록 ▼

Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cel

Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Compositions that are administered to a patient include a mixture of adipose tissue and stem cells so that the composition has a higher concentration of stem cells than when the adipose tissue was removed from the patient.

대표청구항 ▼

1. A method of making an enhanced, autologous fat graft comprising extracting from a subject a first portion of adipose tissue to be used as a fat graft then supplementing said fat graft with a population of concentrated, disaggregated, adipose-derived stem cells and endothelial precursor cells in a

1. A method of making an enhanced, autologous fat graft comprising extracting from a subject a first portion of adipose tissue to be used as a fat graft then supplementing said fat graft with a population of concentrated, disaggregated, adipose-derived stem cells and endothelial precursor cells in a buffered solution, wherein said stem cells and endothelial precursor cells are prepared by disaggregating and concentrating the stem cells and endothelial precursor cells from a second portion of extracted adipose tissue from said subject, so as to make said enhanced, autologous fat graft. 2. The method of claim 1, wherein said disaggregated adipose-derived stem cells and endothelial precursor cells are prepared by: (a) disaggregating said second portion of extracted adipose tissue to generate a cell suspension; and(b) separating a population of adipose-derived cells that comprises stem cells and endothelial precursor cells from the cell suspension by buoyant density sedimentation, filtration, or centrifugation. 3. The method of claim 2, wherein the second portion of extracted adipose tissue is disaggregated in (a) by enzymatic digestion or mechanical force. 4. The method of claim 2, further comprising reducing the presence of mature adipocytes in the cell suspension generated at step (a) prior to step (b). 5. The method of claim 2, wherein the population of adipose-derived cells that comprises stem cells and endothelial precursor cells in (b) is separated by centrifugation. 6. The method of claim 2, wherein the second portion of extracted adipose tissue is disaggregated in (a) by enzymatic digestion. 7. The method of claim 2, wherein said population of concentrated, disaggregated, adipose-derived stem cells and endothelial precursor cells is prepared in a device that operates in a closed system. 8. The method of claim 1, wherein said first portion of extracted adipose tissue is supplemented with said population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells in a device that operates in a closed system. 9. The method of claim 1, wherein said population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells is not cultured. 10. A method of making an enhanced, autologous fat graft comprising: (a) disaggregating a first portion of extracted adipose tissue from a subject with an enzyme or mechanical force to generate a cell suspension;(b) concentrating the cells in said cell suspension by buoyant density sedimentation, filtration or centrifugation to obtain a population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells in a buffered solution; and(c) supplementing a second portion of extracted adipose tissue to be used as a fat graft from said subject with the population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells in the buffered solution, so as to make said enhanced, autologous fat graft. 11. The method of claim 10, wherein the population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells in (b) is prepared by centrifugation. 12. The method of claim 10, wherein said population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells is prepared in a device that operates in a closed system. 13. The method of claim 10, wherein said second portion of extracted adipose tissue is supplemented with said population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells in a device that operates in a closed system. 14. The method of claim 10, further comprising reducing the presence of mature adipocytes in the cell suspension generated at step (a) prior to step (b). 15. The method of claim 10, wherein said population of concentrated, disaggregated adipose-derived stem cells and endothelial precursor cells is not cultured. 16. A method of making an enhanced, autologous fat graft comprising extracting from a subject a first portion of adipose tissue to be used as a fat graft then supplementing said fat graft with a population of concentrated, disaggregated adipose-derived stem cells in a buffered solution, wherein said stem cells are prepared by disaggregating and concentrating the stem cells from a second portion of extracted adipose tissue from said subject, so as to make said enhanced, autologous fat graft. 17. The method of claim 16, wherein said population of concentrated, disaggregated adipose-derived stem cells is not cultured. 18. The method of claim 16, wherein said population of concentrated, disaggregated adipose-derived stem cells is prepared in a device that operates in a closed system. 19. The method of claim 16, wherein said second portion of extracted adipose tissue is supplemented with said population of concentrated, disaggregated stem cells in a device that operates in a closed system. 20. The method of claim 1, wherein the enhanced, autologous fat graft further comprises an additive. 21. The method of claim 10, wherein the enhanced, autologous fat graft further comprises an additive. 22. The method of claim 16, wherein the enhanced, autologous fat graft further comprises an additive.